Skip to Content

ASP: Budesonide reverses course

ASP: Budesonide reverses course

BALTIMORE - When it comes to nebulizer medication pricing, one quarter you're up; another quarter you're down.

Average sales price (ASP) figures for the first quarter of 2014 revealed a decrease for budesonide (J7626) of nearly 35 cents to $5.60 per dose. That's in contrast to the previous quarter, when the drug increased 85 cents.

The only other drugs to see increases for the upcoming quarter: brand names Brovana (J7605) and Perforomist (J7606), which increased 22 cents and 6 cents, respectively. That puts pricing for Brovana at $5.77 and Perforomist at $6.36.

There was relatively little change for other neb meds. Albuterol (J7613) and ipratropium (J7644) were both down less than one cent to just under 12 cents per dose each.


To comment on this post, please log in to your account or set up an account now.